← Leaderboards
Steven Michael Smith
University Of Florida
$1,973,717
Attributed
$2,992,891
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,992,891 · 4
By mechanism
R01$2,038,348 · 2
K01$725,793 · 1
R21$228,750 · 1
Top collaborators
- Carl J Pepine2 shared
- Mark J Pletcher1 shared
Most similar at University Of Florida
Same institution · by research overlap
- Carl J Pepine$14,456,715
- Christy Shawn Carter$5,191,972
- H. Russell Bernard$1,391,367
- Vladimir A Rakov$5,896,967
- George Casella$1,032,237
Others in their field
Other Emerging Leaders on “Hypertension”
- Chanza Baytop · Westat, Inc.$271,217,917
- Michael P Harms · Washington University$13,645,932
- Xinhua Li · Nano Terra, Inc.$11,941,250
- Alberto Rafael Ramos · University Of Miami School Of Medicine$11,324,161
- Katherine Teresa Mills · Tulane University Of Louisiana$11,000,903
- Colin Masters · University Of Melbourne$10,651,748
Research focus
HypertensionBlood PressureAmericanDiureticsHeterogeneityHypertension ControlDesignResponseAffectAccountingCessation Of LifeAdverse EventAntihypertensive AgentsFuturePharmacotherapyResourcesDrug PrescriptionsNational Heart, Lung, And Blood InstituteClinical Decision SupportPharmaceutical PreparationsChronicFundingCaringBlood Pressure Control
Grant awards (10)
Analyzing effectiveness of ongoing natural experiments in telehealth$705,383
R01 · FY2025 · HL · contact PI
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the gut microbiota-brain-immune axis$650,022
R01 · FY2025 · HL · contact PI
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the gut microbiota-brain-immune axis$682,943
R01 · FY2024 · HL · contact PI
High-throughput screening for antihypertensive prescribing cascades$114,375
R21 · FY2023 · HL · contact PI
Advancing Personalized Hypertension Care through Big Data Science$135,950
K01 · FY2022 · HL · contact PI
High-throughput screening for antihypertensive prescribing cascades$114,375
R21 · FY2022 · HL · contact PI
Advancing Personalized Hypertension Care through Big Data Science$152,312
K01 · FY2021 · HL · contact PI
Advancing Personalized Hypertension Care through Big Data Science$142,789
K01 · FY2020 · HL · contact PI
Advancing Personalized Hypertension Care through Big Data Science$143,536
K01 · FY2019 · HL · contact PI
Advancing Personalized Hypertension Care through Big Data Science$151,206
K01 · FY2018 · HL · contact PI